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Abstract— The S-methylation of a macrocyclic tetrathiolactam afforded a new macrocyclic thioimidate that exhibited good affinity toward 
metal ions.  The molecular structures of the macrocyclic ligand and its metal complexes were determined by X-ray crystallography.  © 
2009 Elsevier Science. All rights reserved 
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 Macrocyclic compounds often have molecular recognition 
abilities.1  Polylactams (i.e., macrocyclic amides) have 
recently received considerable interest as hydrogen bonding 
donors due to their ability to include anions and organic 
molecules,2 whereas macrocyclic compounds containing –
N=, –O–, and –S– groups form useful inclusion complexes 
with metal ions, and their widespread applications in 
molecular recognition and metal ion transport are 
expected.3     
Bowman-James’s group and our group previously 
demonstrated that the thionation of polylactams enhances 
the hydrogen donor ability of the hydrogen in the N-H 
group, and the obtained polythiolactams (i.e., macrocyclic 
thioamides) exhibited strong affinity toward anions.4  We 
here report the further chemical transformation of 
polythiolactam, which is effective for inverting the 
inclusion ability of the macrocyclic compound and 
provides a new macrocyclic ligand for metal ions.   
 
Pergamon 
TETRAHEDRON
LETTERS 
N
HNNH
NH HN
N
S
SS
S
Me3OBF4
N
NN
N N
N
S
SS
S MeMe
MeMe
1 2
MXn
N
NN
N N
N
S
SS
S MeMe
MeMe
[2  M]Xn
M
n+
n X-
Scheme 1
This is an author version based on a templated by Elsevier. 
 Tetrahedron Letters  2 
Secondary thioamides have often been used as versatile 
intermediates for synthetic applications in medical and 
organic chemistry,5 and it is known that the S-alkylation of 
secondary thioamides yields thioimidates.6  This situation 
prompted us to carry out the S-methylation of 
polythiolactam 1 to yield a new macrocyclic thioimidate 2, 
as shown in Scheme 1.  2 has six nitrogen lone pair 
electrons facing the cavity and is expected to exhibit strong 
affinity toward metal ions.  Metal complexes of 
macrocyclic ligands with Schiff base units have extensively 
been studied,3,7 and lanthanide(III) complexes with 
macrocyclic hexaaza Schiff base ligands are known to act 
as a catalyst for RNA cleavage.8  However, studies of 
macrocyclic ligands containing the thioimidate group 
remain rare.9  In this paper, preparation and molecular 
structures of metal complexes of 2 ([2·M]Xn) are presented.   
1 was prepared as previously reported.4a  The S-methylation 
of 1 with trimethyloxonium tetrafluoroborate (Me3OBF4) 
afforded 2 in moderate yield (60%),10 whereas a similar 
reaction with a related polylactam 3 did not give the 
corresponding macrocyclic imidate.  The treatment of 2 
with metal salts readily provided metal complexes, [2·M]Xn 
(M = K, Ca, Eu, Er; X = Cl, I, and NO3).11   
The chemical structures of 2 and [2·M]Xn were confirmed 
by spectroscopic methods and X-ray crystallography (see 
below).10-12  Figure 1 shows the 1H NMR spectra of 2 and 
[2·Ca]Cl2 in CDCl3.  The 1H and 13C NMR peaks of 2 
cannot be assigned definitively because of the complex 
signal pattern, although the signals became broader and 
simpler at 130 °C in DMSO-d6.  The stereoisomerism of 2 
in solution is suggested to be due to the E/Z isomerization 
of the thioimidate group.6d  In contrast, complexation with 
a Ca(II) ion is considered to fix the geometry of 2 and 
results in a simplified 1H NMR spectrum, as shown in 
Figure 1(b).  For [2·Eu](NO3)3 and [2·Er](NO3)3, the 
complexation of the paramagnetic metals leads to 
significant changes in the 1H NMR spectrum,13 and the 
photoluminescence spectrum of [2·Eu](NO3)3 exhibits a 
sharp emission peak at 616 nm in CH3CN due to the 5D0 → 7F2 transition of the Eu(III) ion.7,8  The emission 
intensity of [2·Eu](NO3)3 is about four times stronger than 
that of a Eu(III) complex of the macrocyclic hexaaza Schiff 
base ligand ([4·Eu](NO3)3 ).7f,g    
To examine the affinity of 2 toward metal ions, competitive 
complexation experiments on 2 and the known macrocyclic 
ligand, dibenzo-18-crown-6(DB18C6),14 were carried out 
by 1H NMR spectroscopy.  The NMR experiments using 
1:1 mixtures of [2·Ca]Cl2 with DB18C6 and of 
[2·Eu](NO3)3 with DB18C6 showed that 2 exhibited much 
higher affinity toward Ca(II) and Eu(III) ions than DB18C6.  
In neither case was any free 2 detected.  In contrast, the 
NMR spectrum of a 1:1 mixture of [2·K]I with DB18C6 
showed free 2, indicating less affinity of 2 toward K+ ion 
than that of DB18C6.  
Figure 1.  1H NMR spectra of (a) 2 and (b) [2·Ca]Cl2 (400 MHz, CDCl3, 
298 K).  Peaks marked with an asterisk * are due to solvent impurities.   
The ORTEP drawings of 2, [2·Ca]Cl2, and [2·Eu](NO3)3 are 
presented in Figure 2.12  In the X-ray quality single crystals 
of 2, the asymmetric unit of 2 consists of two halves of two 
independent and discrete molecules.  Figure 2(a) indicates 
that 2 adopts an approximately C2v conformation, and the 
two pyridine rings are heavily tilted in opposite directions 
from the center circle with dihedral angles of 39.20 and 
46.31°, presumably due to electronic repulsion between the 
lone pair electrons of the nitrogen atoms.  In contrast, as 
shown in Figures 2(b) and (c), the complexation of 2 with 
metal ions leads to a well-fitted accommodation of a metal 
ion in the cavity, which induces reductions in the dihedral 
angles between the pyridine rings and the macrocyclic 
framework of 32.25 and 24.16°, respectively.  For 
[2·Eu](NO3)3, the two pyridine rings are twisted with a 
dihedral angle of 48.33° upon coordination to a Eu(III) ion.  
In both complexes, the metal atom is bound to all six 
nitrogen atoms of 2 with Ca-N and Eu-N atom distances of 
2.708-2.825 and 2.598-2.631 Å, respectively.  The Eu-N 
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atom distances are consistent with those reported for the Eu 
complexes of the macrocyclic hexaaza Schiff base ligand 
(2.564-2.747 Å).15   
In contrast to extensive studies of the metal complexes with 
4,3,7,8 to our knowledge, the isolation of 4 has not been 
successful presumably due to the poor resistance of the 
imine bonds of 4 toward hydrolysis.7d,e,8b  The resistance of 
2 toward hydrolysis in basic and acidic media was 
evaluated using 1H NMR spectroscopy in CDCl3.  The 
treatment of a CDCl3 solution of 2 with aqueous NaOH 
gave essentially the same NMR spectrum after 1 week.  
The addition of aqueous trifluoroacetic acid led to the 
protonation of 2; however, the spectrum remained 
unchanged over 1 week.  The treatment of the solution with 
Na2CO3 gave essentially the same NMR spectrum as that of 
the original 2.  Therefore, 2 seems to be a stable ligand and 
can serve as a good ionophore for various metal ions.   
Figure 2.  X-ray crystal structures of (a) 2, (b) [2·Ca]Cl2, and (c) 
[2·Eu](NO3)3 with thermal ellipsoids drawn at the 50% probability level.  
One of the two crystallographically independent molecules of 2 is shown.  
Hydrogen atoms, anions, and solvated molecules are omitted for 
simplicity.   
As described above, 1 is not only a good anion receptor but 
also a useful starting material for the preparation of a new 
macrocyclic thioimidate 2.  2 is a stable macrocyclic ligand 
that forms complexes with metal ions.  This synthetic 
protocol is practical for the design of various macrocyclic 
ligands and ionophores for metal ions.    
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ORTEP drawings of [2·K]I and [2·Er](NO3)3.  
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656962 ([2·K]I), 656963 ([2·Ca]Cl2 ·CH3CN), 656964 
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